Evidence map›Paper›PMID 38136138›Full record

ArticleChildren (Basel, Switzerland)2023

The Impact of

Hyun Jin Park, Jung Yoon Choi, Bo Kyung Kim, Kyung Taek Hong, Hyun-Young Kim, Il Han Kim, Gi Jeong Cheon, Jung-Eun Cheon, Sung-Hye Park, Hyoung Jin Kang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hyun Jin ParkDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-7062-0414
Jung Yoon ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Bo Kyung KimDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kyung Taek HongDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-8822-1988
Hyun-Young KimDepartment of Pediatric Surgery, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Il Han KimSeoul National University Cancer Research Institute, Seoul 03080, Republic of Korea.
Gi Jeong CheonSeoul National University Cancer Research Institute, Seoul 03080, Republic of Korea.
Jung-Eun CheonDepartment of Radiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Sung-Hye ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-8681-1597
Hyoung Jin KangDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Seoul National University · KR

Funding

Seoul National University Hospital 0320200110
6 · The paper itself

Abstract

backgroundThe optimal conditioning regimen of tandem high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) for high-risk neuroblastoma (HR-NBL) has not been established. The efficacy of

methodsWe retrospectively analyzed the clinical data of 33 HR-NBL patients who underwent tandem HDC/ASCT between 2007 and 2021 at the Seoul National University Children's Hospital.

resultsThe median age at diagnosis was 3.6 years.

conclusionsAlthough tandem HDC/ASCT showed promising outcomes, the

Indexed as

autologous stem cell transplantationchemotherapyneuroblastomapediatrics

Identifiers

PMID38136138
PMCPMC10742322
OpenAlexW4389913493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.